Stockreport

Milestone Pharmaceuticals (MIST): Taking Stock of Valuation After FDA Approval of CARDAMYST Nasal Spray [Yahoo! Finance]

Milestone Pharmaceuticals Inc. - Common Shares  (MIST) 
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am Check Earnings Report
PDF See our latest analysis for Milestone Pharmaceuticals. The FDA approval lands at an interesting time for investors, with Milestone's 30 day share price return of 17.2 [Read more]